Disease Overview：Ovulation induction（OI）
Ovulation induction (OI) is a cornerstone fertility treatment in reproductive endocrinology, primarily indicated for women with anovulation—such as those with polycystic ovary syndrome (PCOS), hypothalamic amenorrhea, or unexplained infertility. It involves the strategic use of pharmacologic agents—including clomiphene citrate, letrozole, or gonadotropins—to stimulate follicular development and trigger timely ovulation. Treatment is closely monitored via transvaginal ultrasound and serum estradiol/luteinizing hormone assays to optimize follicular cohort size, minimize risks of ovarian hyperstimulation syndrome (OHSS) and multiple gestation, and time intercourse or intrauterine insemination (IUI) precisely. Success rates vary by etiology and age but typically range from 10–20% per cycle for conception, with cumulative live birth rates reaching 60–80% over six cycles in well-selected patients.
China offers distinct advantages for international patients seeking ovulation induction: its reproductive medicine centers—many accredited by the National Health Commission and affiliated with top-tier universities—employ board-certified reproductive endocrinologists trained in evidence-based protocols. Advanced real-time ultrasound systems, automated hormone analyzers, and AI-assisted follicular tracking enhance precision and safety. With over 500,000 annual assisted reproductive technology (ART) cycles performed nationally, Chinese clinics report robust clinical outcomes, including OHSS rates below 1% in standardized OI protocols. Crucially, costs are 40–60% lower than in the US, UK, or Australia—without compromising care quality. As a dedicated medical tourism agency, we facilitate seamless access: vetting JCI-aligned hospitals, securing priority consultations, providing itemized, transparent pricing in advance, and delivering end-to-end support—from visa assistance and accommodation coordination to bilingual nursing liaison and post-treatment follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Ovulation Induction (Reproductive Medicine Department)
Non-Surgical / Medication-Based Options
*Target Criteria:* Anovulation (PCOS, hypothalamic amenorrhea), oligo-ovulation, unexplained infertility; normal tubal patency and semen parameters.
- •Clomiphene Citrate (CC) First-Line Therapy
- *Tier 2 (Enhanced Monitoring):* CC + 3–4 TVUS + E₂/P₄ + LH surge testing + endometrial assessment → $260–$310
- •Letrozole (Aromatase Inhibitor)
- *Tier 2:* Letrozole + 3–4 TVUS + E₂/LH/P₄ + insulin resistance panel (fasting glucose, insulin, HOMA-IR) → $410–$470
- •Gonadotropin Injection (hMG/rFSH)
- *Tier 2:* Individualized rFSH/hMG + daily TVUS + E₂ × 3 + P₄ + progesterone support → $950–$1,130
*Baseline Lab/Exam Fees (per cycle, mandatory):*
- •Pelvic ultrasound (TVUS): $35
- •Serum hormone panel (FSH, LH, E₂, P₄, AMH, TSH, prolactin): $110
- •Glucose tolerance test (if PCOS/metabolic risk): $45
Surgical/Procedural Options
*Eligibility Criteria:* Clomiphene/Letrozole resistance after ≥3 cycles; severe PCOS with ovarian stromal hyperplasia; BMI <35 kg/m²; no contraindications to laparoscopy.
- •Laparoscopic Ovarian Drilling (LOD)
- Procedure (bipolar cautery, 4–6 punctures per ovary, intraoperative dye test): $2,100–$2,550 - Post-op monitoring (24-hr observation, pain control, follow-up TVUS at Day 3): $140
Special/Complex Condition Management
- •Hypothalamic Amenorrhea (HA) with Low BMI (<18.5): Cognitive-behavioral nutrition counseling + pulsatile GnRH pump (6–12 weeks): $3,800–$4,600
- •Hyperprolactinemia (PRL >100 ng/mL): Cabergoline titration + monthly PRL + MRI brain (if macroadenoma suspected): $520–$780/cycle
- •Insulin Resistance–Driven PCOS: Metformin + Letrozole + lifestyle intervention (certified dietitian + 8-week program): $640–$890/cycle
Quick Selection Guide
- •<35 years, PCOS, budget-conscious: Start with Letrozole Tier 1 ($290–$340) — highest live birth rate per dollar in this cohort.
- •35–40 years, prior CC failure, moderate budget: Advance to Gonadotropin Tier 1 ($680–$820) with strict cycle cancellation protocols to avoid OHSS.
- •>40 years or diminished reserve (AMH <1.0 ng/mL): Skip oral agents; proceed directly to Gonadotropin Tier 2 ($950–$1,130) with adjunctive growth hormone (if available).
- •BMI ≥30 + clomiphene-resistant PCOS: Prioritize LOD ($2,100–$2,550) — cost-effective long-term ovulation restoration vs. repeated gonadotropin cycles.
- •Hypothalamic amenorrhea or hyperprolactinemia: Use condition-specific protocols — avoid empiric gonadotropins due to high miscarriage/OHSS risk.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Ovulation induction Medical Vacation Packages
Curated transparent all-inclusive packages combining Ovulation induction treatment with China top medical destinations:
